Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa1
|
ENSMUSG00000029844.9 | homeobox A1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52157866_52158017 | Hoxa1 | 376 | 0.456035 | 0.48 | 2.1e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_42686006_42686763 | 18.93 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6709 |
0.14 |
chrX_102003725_102004324 | 18.58 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr3_137680957_137681359 | 15.65 |
Gm21962 |
predicted gene, 21962 |
9634 |
0.14 |
chr16_85092305_85093056 | 13.83 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr18_55379560_55379763 | 13.67 |
Gm37828 |
predicted gene, 37828 |
40149 |
0.2 |
chr2_33543695_33544688 | 13.48 |
Gm13530 |
predicted gene 13530 |
54409 |
0.1 |
chr8_12928887_12929303 | 13.34 |
Mcf2l |
mcf.2 transforming sequence-like |
2463 |
0.18 |
chr9_13246797_13247848 | 13.13 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr1_85282930_85283466 | 12.84 |
Gm16026 |
predicted pseudogene 16026 |
8091 |
0.13 |
chr1_12811190_12811461 | 12.67 |
Sulf1 |
sulfatase 1 |
24703 |
0.22 |
chr17_8524507_8524753 | 12.59 |
Pde10a |
phosphodiesterase 10A |
742 |
0.68 |
chr16_63806861_63807216 | 12.50 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr17_49538907_49539627 | 12.48 |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
25039 |
0.21 |
chr16_35587590_35588108 | 12.22 |
Gm5963 |
predicted pseudogene 5963 |
14293 |
0.18 |
chr15_25754647_25755340 | 12.13 |
Myo10 |
myosin X |
2014 |
0.38 |
chr14_19584067_19584422 | 12.04 |
Gm2237 |
predicted gene 2237 |
891 |
0.43 |
chr14_4856308_4856633 | 11.98 |
Gm3264 |
predicted gene 3264 |
894 |
0.49 |
chr13_29273638_29274140 | 11.95 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr14_3810787_3811147 | 11.92 |
Gm3002 |
predicted gene 3002 |
893 |
0.48 |
chr1_10596534_10596685 | 11.84 |
Gm25253 |
predicted gene, 25253 |
40949 |
0.15 |
chr14_5502289_5502728 | 11.77 |
Gm3488 |
predicted gene, 3488 |
834 |
0.47 |
chr14_4183274_4183610 | 11.70 |
Gm2974 |
predicted gene 2974 |
866 |
0.5 |
chr14_70659174_70659883 | 11.67 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr13_12340200_12340584 | 11.55 |
Actn2 |
actinin alpha 2 |
332 |
0.88 |
chr8_125390573_125390802 | 11.55 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
102023 |
0.07 |
chr14_5960610_5960983 | 11.39 |
Gm3248 |
predicted gene 3248 |
949 |
0.39 |
chr14_3413380_3413693 | 11.34 |
Gm10409 |
predicted gene 10409 |
922 |
0.43 |
chr3_89215441_89216252 | 11.22 |
Thbs3 |
thrombospondin 3 |
613 |
0.38 |
chr17_55445138_55445530 | 11.21 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
48 |
0.98 |
chr14_4415827_4416278 | 11.17 |
Gm3164 |
predicted gene 3164 |
604 |
0.63 |
chr14_6888825_6889165 | 11.11 |
Gm3667 |
predicted gene 3667 |
967 |
0.55 |
chr7_73390556_73391998 | 11.02 |
Rgma |
repulsive guidance molecule family member A |
1 |
0.97 |
chr6_101198204_101198658 | 11.02 |
Gm26911 |
predicted gene, 26911 |
138 |
0.9 |
chr4_143300001_143300152 | 10.96 |
Pdpn |
podoplanin |
512 |
0.76 |
chr7_18950757_18950953 | 10.62 |
Nova2 |
NOVA alternative splicing regulator 2 |
24967 |
0.07 |
chr14_115092118_115092966 | 10.36 |
Gpc5 |
glypican 5 |
84 |
0.96 |
chr13_96130906_96131482 | 10.32 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1383 |
0.35 |
chr11_32002527_32003111 | 10.32 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr14_4019574_4019907 | 10.31 |
Gm5796 |
predicted gene 5796 |
4201 |
0.15 |
chr5_125151891_125152362 | 10.19 |
Ncor2 |
nuclear receptor co-repressor 2 |
26927 |
0.18 |
chr12_17048993_17049526 | 10.18 |
Gm48538 |
predicted gene, 48538 |
16154 |
0.17 |
chr10_33624125_33624337 | 10.18 |
Gm15939 |
predicted gene 15939 |
15 |
0.5 |
chr14_6426045_6426452 | 10.08 |
Lamtor3-ps |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3, pseudogene |
13766 |
0.14 |
chr10_51011824_51012041 | 10.03 |
Sim1 |
single-minded family bHLH transcription factor 1 |
116281 |
0.06 |
chr8_47287521_47288218 | 10.01 |
Stox2 |
storkhead box 2 |
1493 |
0.48 |
chr14_7657542_7657949 | 9.98 |
Gm10128 |
predicted gene 10128 |
13773 |
0.16 |
chr1_112416821_112417012 | 9.98 |
Gm18406 |
predicted gene, 18406 |
12061 |
0.27 |
chr8_86389967_86390620 | 9.98 |
Gm24490 |
predicted gene, 24490 |
97792 |
0.07 |
chr9_29523209_29523462 | 9.93 |
Gm15521 |
predicted gene 15521 |
69175 |
0.13 |
chr18_37089713_37090118 | 9.88 |
Pcdhac1 |
protocadherin alpha subfamily C, 1 |
98 |
0.94 |
chr3_136456846_136457013 | 9.78 |
1700030L20Rik |
RIKEN cDNA 1700030L20 gene |
7580 |
0.28 |
chr16_91962945_91963627 | 9.78 |
Gm27773 |
predicted gene, 27773 |
19138 |
0.1 |
chr18_55733414_55733925 | 9.76 |
Gm26959 |
predicted gene, 26959 |
12559 |
0.26 |
chr14_5387971_5388348 | 9.75 |
Gm3500 |
predicted gene 3500 |
890 |
0.46 |
chr14_6107595_6107954 | 9.66 |
Gm3468 |
predicted gene 3468 |
891 |
0.45 |
chr11_96876294_96876734 | 9.63 |
Gm11523 |
predicted gene 11523 |
2560 |
0.14 |
chr13_51259220_51259624 | 9.63 |
Gm29787 |
predicted gene, 29787 |
53311 |
0.1 |
chr15_74515701_74516138 | 9.63 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
276 |
0.92 |
chr12_27566321_27566542 | 9.62 |
Gm4166 |
predicted gene 4166 |
31770 |
0.22 |
chr14_75482334_75482951 | 9.61 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
26660 |
0.19 |
chr15_45114403_45115128 | 9.53 |
Kcnv1 |
potassium channel, subfamily V, member 1 |
62 |
0.98 |
chr14_3049596_3050027 | 9.47 |
Gm2897 |
predicted gene 2897 |
526 |
0.7 |
chr18_22419049_22419248 | 9.44 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
74059 |
0.13 |
chr3_102012111_102012602 | 9.43 |
Nhlh2 |
nescient helix loop helix 2 |
2201 |
0.31 |
chr5_42067440_42068088 | 9.42 |
Gm16223 |
predicted gene 16223 |
196 |
0.97 |
chr14_7173812_7174215 | 9.40 |
Gm3512 |
predicted gene 3512 |
520 |
0.73 |
chr11_114467854_114468223 | 9.39 |
4932435O22Rik |
RIKEN cDNA 4932435O22 gene |
19178 |
0.23 |
chr3_101145380_101145593 | 9.36 |
Ptgfrn |
prostaglandin F2 receptor negative regulator |
35208 |
0.14 |
chr14_46647395_46647602 | 9.35 |
4933425B07Rik |
RIKEN cDNA 4933425B07 gene |
10075 |
0.11 |
chr6_37299891_37300077 | 9.31 |
Dgki |
diacylglycerol kinase, iota |
10 |
0.99 |
chr8_123617360_123617734 | 9.31 |
n-R5s146 |
nuclear encoded rRNA 5S 146 |
619 |
0.21 |
chr2_152951550_152952069 | 9.17 |
Dusp15 |
dual specificity phosphatase-like 15 |
111 |
0.94 |
chr11_44977646_44977797 | 9.10 |
Ebf1 |
early B cell factor 1 |
65583 |
0.13 |
chr10_70949541_70949751 | 9.09 |
Bicc1 |
BicC family RNA binding protein 1 |
1157 |
0.46 |
chr10_42220647_42220798 | 9.07 |
Foxo3 |
forkhead box O3 |
37644 |
0.19 |
chr13_73034418_73035007 | 9.07 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
198683 |
0.02 |
chr8_82004303_82004454 | 9.03 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
114059 |
0.06 |
chr13_94706902_94707053 | 8.98 |
Gm32351 |
predicted gene, 32351 |
4259 |
0.18 |
chrX_169827022_169827212 | 8.96 |
Mid1 |
midline 1 |
1042 |
0.62 |
chr14_4650174_4650618 | 8.93 |
Gm3239 |
predicted gene 3239 |
13796 |
0.11 |
chr12_77854688_77854985 | 8.86 |
Gm8219 |
predicted gene 8219 |
35254 |
0.18 |
chr9_51766490_51766741 | 8.86 |
Arhgap20 |
Rho GTPase activating protein 20 |
955 |
0.65 |
chr6_77075373_77076013 | 8.86 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
68250 |
0.13 |
chr4_125315838_125316245 | 8.83 |
1700041M05Rik |
RIKEN cDNA 1700041M05 gene |
87444 |
0.08 |
chr1_24245817_24245999 | 8.76 |
Col9a1 |
collagen, type IX, alpha 1 |
16391 |
0.25 |
chr9_89496663_89497009 | 8.73 |
Gm47403 |
predicted gene, 47403 |
63548 |
0.11 |
chr15_68650136_68650317 | 8.66 |
Gm25987 |
predicted gene, 25987 |
21190 |
0.19 |
chr14_103649953_103650335 | 8.66 |
Slain1 |
SLAIN motif family, member 1 |
84 |
0.85 |
chr4_148384170_148384515 | 8.60 |
Gm13200 |
predicted gene 13200 |
24882 |
0.14 |
chr1_166282380_166283234 | 8.59 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
26778 |
0.14 |
chr5_76702101_76702252 | 8.54 |
Gm7494 |
predicted gene 7494 |
40337 |
0.13 |
chr4_54945565_54946178 | 8.47 |
Zfp462 |
zinc finger protein 462 |
823 |
0.73 |
chr5_76079721_76079918 | 8.45 |
Gm6051 |
predicted gene 6051 |
19056 |
0.16 |
chr9_28226367_28226518 | 8.41 |
Gm15606 |
predicted gene 15606 |
28502 |
0.23 |
chr1_176099468_176099619 | 8.37 |
Gm38081 |
predicted gene, 38081 |
66820 |
0.1 |
chr14_3333318_3333683 | 8.36 |
Gm2956 |
predicted gene 2956 |
873 |
0.51 |
chr3_134416016_134416246 | 8.31 |
4930539C22Rik |
RIKEN cDNA 4930539C22 gene |
7504 |
0.23 |
chr6_134207480_134208194 | 8.29 |
Etv6 |
ets variant 6 |
25763 |
0.14 |
chr18_21654663_21654851 | 8.29 |
Klhl14 |
kelch-like 14 |
39 |
0.98 |
chr12_39956297_39956455 | 8.27 |
Gm18939 |
predicted gene, 18939 |
5744 |
0.21 |
chr4_150769131_150769447 | 8.25 |
Gm13049 |
predicted gene 13049 |
56444 |
0.1 |
chr2_113828734_113829247 | 8.23 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr9_91365711_91366045 | 8.22 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr14_68083721_68083923 | 8.22 |
Nefl |
neurofilament, light polypeptide |
41 |
0.97 |
chr7_139683757_139684619 | 8.19 |
Cfap46 |
cilia and flagella associated protein 46 |
371 |
0.85 |
chr19_6428916_6429084 | 8.18 |
Nrxn2 |
neurexin II |
354 |
0.76 |
chr11_115350061_115350323 | 8.17 |
Hid1 |
HID1 domain containing |
811 |
0.42 |
chr7_4844982_4845300 | 8.16 |
Shisa7 |
shisa family member 7 |
445 |
0.64 |
chr2_12709705_12709871 | 8.16 |
Gm37565 |
predicted gene, 37565 |
12371 |
0.29 |
chr7_64626494_64626647 | 8.14 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
8461 |
0.26 |
chr13_78194795_78195669 | 8.13 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1141 |
0.38 |
chr10_25929030_25929439 | 8.12 |
Gm47939 |
predicted gene, 47939 |
29955 |
0.15 |
chr14_122481225_122481538 | 8.09 |
Zic2 |
zinc finger protein of the cerebellum 2 |
3281 |
0.14 |
chrX_73880149_73880806 | 8.09 |
L1cam |
L1 cell adhesion molecule |
318 |
0.8 |
chr5_144479710_144479886 | 8.03 |
Nptx2 |
neuronal pentraxin 2 |
66104 |
0.1 |
chr13_60176337_60177409 | 8.01 |
Gas1 |
growth arrest specific 1 |
68 |
0.67 |
chr1_85585452_85586237 | 7.99 |
Sp110 |
Sp110 nuclear body protein |
1566 |
0.22 |
chr7_141468254_141469266 | 7.99 |
Cd151 |
CD151 antigen |
62 |
0.89 |
chr9_75610077_75610239 | 7.95 |
Tmod2 |
tropomodulin 2 |
917 |
0.49 |
chr14_6037130_6037453 | 7.91 |
Gm8206 |
predicted gene 8206 |
918 |
0.4 |
chr13_63239486_63240276 | 7.90 |
Aopep |
aminopeptidase O |
148 |
0.91 |
chr15_12740269_12740457 | 7.89 |
Pdzd2 |
PDZ domain containing 2 |
439 |
0.78 |
chr11_32001599_32001931 | 7.87 |
Nsg2 |
neuron specific gene family member 2 |
1263 |
0.5 |
chr10_46045847_46046012 | 7.86 |
Gpx4-ps2 |
glutathione peroxidase 4, pseudogene 2 |
170624 |
0.03 |
chr4_91399907_91400116 | 7.85 |
Elavl2 |
ELAV like RNA binding protein 1 |
27 |
0.98 |
chr13_28847622_28847787 | 7.83 |
Gm11362 |
predicted gene 11362 |
10829 |
0.18 |
chr8_86385246_86385589 | 7.83 |
Gm24490 |
predicted gene, 24490 |
92916 |
0.08 |
chr3_26153515_26153806 | 7.83 |
Nlgn1 |
neuroligin 1 |
353 |
0.93 |
chr13_69988460_69988640 | 7.81 |
Gm47655 |
predicted gene, 47655 |
19064 |
0.15 |
chrX_11533974_11534129 | 7.80 |
Gm14515 |
predicted gene 14515 |
67303 |
0.11 |
chr1_88254702_88255947 | 7.80 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr7_77812173_77812357 | 7.79 |
Gm23239 |
predicted gene, 23239 |
98055 |
0.09 |
chr15_102807462_102807613 | 7.78 |
Gm36560 |
predicted gene, 36560 |
10042 |
0.15 |
chr2_102663968_102664136 | 7.75 |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
4771 |
0.26 |
chr15_86689893_86690044 | 7.71 |
Gm49464 |
predicted gene, 49464 |
14323 |
0.21 |
chr14_119582119_119582270 | 7.70 |
Gm6212 |
predicted gene 6212 |
61818 |
0.14 |
chr18_45898377_45898753 | 7.65 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
2056 |
0.4 |
chr14_5879251_5879602 | 7.62 |
Gm8237 |
predicted gene 8237 |
956 |
0.39 |
chr19_10413660_10414496 | 7.59 |
Syt7 |
synaptotagmin VII |
10060 |
0.14 |
chr19_33391464_33392505 | 7.59 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chr16_14906813_14906989 | 7.55 |
Efcab1 |
EF-hand calcium binding domain 1 |
236 |
0.95 |
chr17_32809850_32810208 | 7.55 |
Zfp811 |
zinc finger protein 811 |
98 |
0.5 |
chr14_66343930_66344374 | 7.52 |
Stmn4 |
stathmin-like 4 |
144 |
0.95 |
chr14_79701143_79701381 | 7.48 |
Gm49042 |
predicted gene, 49042 |
1148 |
0.36 |
chr14_6604129_6604479 | 7.48 |
Gm3629 |
predicted gene 3629 |
13691 |
0.15 |
chr6_122495435_122495873 | 7.46 |
Rimklb |
ribosomal modification protein rimK-like family member B |
3107 |
0.17 |
chr3_42427419_42427578 | 7.45 |
Gm38274 |
predicted gene, 38274 |
64721 |
0.14 |
chr15_25412152_25412663 | 7.44 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
1291 |
0.33 |
chr11_32008295_32008467 | 7.39 |
Nsg2 |
neuron specific gene family member 2 |
7879 |
0.22 |
chr15_103519338_103519794 | 7.36 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr3_88756395_88756621 | 7.36 |
Syt11 |
synaptotagmin XI |
4457 |
0.11 |
chr2_93283751_93284270 | 7.34 |
Tspan18 |
tetraspanin 18 |
28505 |
0.19 |
chr11_117478577_117478870 | 7.33 |
Gm34418 |
predicted gene, 34418 |
3874 |
0.18 |
chr6_100705098_100705249 | 7.24 |
Gxylt2 |
glucoside xylosyltransferase 2 |
418 |
0.81 |
chr14_35095601_35095765 | 7.22 |
Gm49034 |
predicted gene, 49034 |
123755 |
0.06 |
chr4_125535545_125535714 | 7.17 |
Mir692-2 |
microRNA 692-2 |
30880 |
0.17 |
chr6_142835752_142836097 | 7.16 |
Gm7457 |
predicted gene 7457 |
21539 |
0.16 |
chr4_82271547_82271698 | 7.14 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
167788 |
0.03 |
chr2_65845684_65845860 | 7.14 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
5 |
0.98 |
chr4_119463218_119463675 | 7.12 |
Zmynd12 |
zinc finger, MYND domain containing 12 |
18726 |
0.09 |
chr7_65060475_65060655 | 7.12 |
Fam189a1 |
family with sequence similarity 189, member A1 |
95851 |
0.07 |
chr4_17853718_17854139 | 7.09 |
Mmp16 |
matrix metallopeptidase 16 |
335 |
0.94 |
chr12_37988361_37988598 | 7.03 |
Dgkb |
diacylglycerol kinase, beta |
29235 |
0.2 |
chr13_83744413_83744884 | 7.02 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5785 |
0.13 |
chr14_5961062_5962084 | 7.00 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr2_62807459_62807865 | 6.99 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr10_103726584_103727032 | 6.99 |
Gm47224 |
predicted gene, 47224 |
131524 |
0.04 |
chr18_47648120_47648271 | 6.98 |
Gm5236 |
predicted gene 5236 |
81572 |
0.08 |
chr9_102235369_102235971 | 6.92 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr4_45822696_45822848 | 6.91 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
4151 |
0.18 |
chr16_87268014_87268522 | 6.90 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
85917 |
0.08 |
chr9_37453861_37454564 | 6.89 |
Robo3 |
roundabout guidance receptor 3 |
20966 |
0.1 |
chrX_75577904_75578367 | 6.88 |
Rab39b |
RAB39B, member RAS oncogene family |
96 |
0.91 |
chr13_70178074_70178256 | 6.86 |
Gm26018 |
predicted gene, 26018 |
9333 |
0.2 |
chr3_138851864_138852151 | 6.85 |
Tspan5 |
tetraspanin 5 |
8486 |
0.22 |
chr3_158559650_158560260 | 6.80 |
Lrrc7 |
leucine rich repeat containing 7 |
1381 |
0.57 |
chr2_112733041_112733261 | 6.80 |
Ryr3 |
ryanodine receptor 3 |
76603 |
0.1 |
chr16_24314048_24314216 | 6.80 |
AC169509.1 |
BMP2 inducible kinase (Bmp2k) pseudogene |
24296 |
0.17 |
chr3_34559225_34559387 | 6.76 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1022 |
0.48 |
chr9_4796326_4796601 | 6.75 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
229 |
0.96 |
chr12_12828155_12828449 | 6.74 |
Gm48187 |
predicted gene, 48187 |
37268 |
0.12 |
chr16_64868727_64868878 | 6.73 |
Cggbp1 |
CGG triplet repeat binding protein 1 |
16100 |
0.16 |
chr3_114508052_114508222 | 6.72 |
Gm43749 |
predicted gene 43749 |
36635 |
0.24 |
chr16_89529954_89530164 | 6.69 |
Krtap7-1 |
keratin associated protein 7-1 |
21736 |
0.15 |
chr17_27203606_27204996 | 6.68 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr11_113144264_113144583 | 6.63 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
28654 |
0.23 |
chr5_37858239_37858390 | 6.62 |
Msx1 |
msh homeobox 1 |
33731 |
0.15 |
chr15_57508617_57508795 | 6.61 |
Gm49235 |
predicted gene, 49235 |
19835 |
0.2 |
chr18_83523941_83524284 | 6.60 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr11_118569825_118570019 | 6.58 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
12 |
0.98 |
chr8_12051470_12051621 | 6.57 |
B020031H02Rik |
RIKEN cDNA B020031H02 gene |
103206 |
0.06 |
chr3_110143512_110144184 | 6.53 |
Ntng1 |
netrin G1 |
163 |
0.97 |
chr8_106336899_106337235 | 6.53 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
921 |
0.59 |
chr14_12391498_12391668 | 6.51 |
Gm48267 |
predicted gene, 48267 |
10647 |
0.13 |
chr14_54577785_54578159 | 6.50 |
Ajuba |
ajuba LIM protein |
414 |
0.66 |
chr6_36809275_36810322 | 6.50 |
Ptn |
pleiotrophin |
381 |
0.91 |
chr2_137113558_137113709 | 6.49 |
Jag1 |
jagged 1 |
3011 |
0.36 |
chr9_29893143_29893294 | 6.46 |
Ntm |
neurotrimin |
69901 |
0.13 |
chr15_78948233_78948500 | 6.45 |
Triobp |
TRIO and F-actin binding protein |
121 |
0.91 |
chr3_107176716_107176892 | 6.43 |
Kcna10 |
potassium voltage-gated channel, shaker-related subfamily, member 10 |
6252 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.4 | 10.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.4 | 10.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.3 | 10.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.0 | 9.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.8 | 8.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.7 | 10.8 | GO:0046959 | habituation(GO:0046959) |
2.7 | 8.0 | GO:1903935 | response to sodium arsenite(GO:1903935) |
2.6 | 15.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.5 | 10.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.5 | 4.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.4 | 19.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.3 | 9.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.3 | 6.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.2 | 6.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.1 | 6.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.1 | 6.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.1 | 6.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.0 | 6.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.9 | 5.8 | GO:0051182 | coenzyme transport(GO:0051182) |
1.8 | 7.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.8 | 5.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.7 | 1.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.7 | 6.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.7 | 8.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.7 | 13.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.7 | 5.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.6 | 6.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.6 | 3.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.6 | 6.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.5 | 4.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.5 | 4.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.5 | 8.8 | GO:0015884 | folic acid transport(GO:0015884) |
1.5 | 5.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.4 | 2.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.4 | 2.8 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.4 | 1.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.3 | 4.0 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.3 | 6.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.3 | 5.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.3 | 5.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 3.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 4.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 3.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 2.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.2 | 12.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 2.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.2 | 2.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 2.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.2 | 5.8 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
1.2 | 1.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.1 | 5.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 11.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 5.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.1 | 5.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.1 | 1.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 5.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.0 | 3.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.0 | 3.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
1.0 | 11.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.0 | 2.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.0 | 4.9 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.0 | 2.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.0 | 5.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 5.8 | GO:0016266 | O-glycan processing(GO:0016266) |
1.0 | 2.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 1.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.0 | 2.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.9 | 0.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 13.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.9 | 5.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.9 | 1.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.9 | 2.7 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.9 | 3.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 3.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.9 | 2.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.9 | 3.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.9 | 1.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.9 | 3.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.9 | 0.9 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.8 | 3.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.8 | 3.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 1.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.8 | 1.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 9.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 3.3 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 2.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.8 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.8 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 3.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.8 | 2.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 3.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.8 | 4.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 6.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.8 | 2.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 1.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.8 | 2.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 4.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.7 | 3.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.7 | 4.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 2.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 3.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.7 | 2.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 9.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.7 | 2.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 2.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 2.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.7 | 4.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 1.3 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 1.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.6 | 1.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.6 | 0.6 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 0.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.6 | 2.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 1.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 4.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 2.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 35.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 8.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 1.2 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.6 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 8.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 1.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.6 | 1.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 2.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 2.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 3.3 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.5 | 1.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.5 | 2.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 1.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 1.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 2.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 8.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 1.0 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.5 | 0.5 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 1.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 7.9 | GO:0060914 | heart formation(GO:0060914) |
0.5 | 1.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 1.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 2.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 0.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 1.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 2.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 1.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 0.9 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.5 | 0.9 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 0.9 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.5 | 1.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 2.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 2.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 2.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 3.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.4 | 5.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 1.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 1.3 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 1.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 1.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 1.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.4 | 0.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 3.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 1.3 | GO:0051181 | cofactor transport(GO:0051181) |
0.4 | 3.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 2.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 5.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.4 | 4.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.4 | 1.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 4.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 2.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 0.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 1.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 1.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 2.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.4 | 1.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 0.7 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.4 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 1.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 24.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 11.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 1.5 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.4 | 1.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 2.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 1.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 2.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 1.8 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.4 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.8 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.3 | 4.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 2.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 1.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 2.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 0.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 2.7 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.3 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 0.3 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.3 | 0.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 2.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.9 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 4.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 6.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.9 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 3.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.6 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.3 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 2.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 2.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 1.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 5.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 0.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.8 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.3 | 1.4 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.3 | 1.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 3.2 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 0.8 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 1.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 1.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 4.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 2.8 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 4.7 | GO:0032835 | glomerulus development(GO:0032835) |
0.2 | 0.7 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 8.1 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 3.4 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 6.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.5 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 7.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.2 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 0.5 | GO:0003358 | noradrenergic neuron differentiation(GO:0003357) noradrenergic neuron development(GO:0003358) |
0.2 | 0.5 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.2 | 0.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 2.1 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 1.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 2.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 2.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.2 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 4.3 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.2 | 1.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 1.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 3.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 2.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 3.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 1.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.4 | GO:1900623 | monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 4.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 3.9 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.2 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 0.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 1.3 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.5 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.2 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 2.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.2 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.2 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.7 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.5 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.2 | 0.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.6 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.6 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 1.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.6 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.1 | 0.3 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.1 | 0.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 1.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 1.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 14.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.7 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.3 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.5 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.5 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 1.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.6 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.1 | GO:0043134 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 4.8 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 1.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 2.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.2 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.5 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 1.2 | GO:0043476 | pigment accumulation(GO:0043476) |
0.1 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.3 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.3 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.5 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 1.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.9 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 1.0 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 1.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.1 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.1 | 0.2 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 1.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.5 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 1.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.4 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.1 | 0.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 1.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.7 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 1.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.1 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.9 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.3 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.0 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 1.8 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.7 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.0 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.0 | 6.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.8 | 7.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.7 | 8.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 18.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.3 | 4.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.2 | 11.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.1 | 3.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 9.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 5.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.0 | 3.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 5.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.0 | 3.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 6.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 11.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.9 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 2.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 2.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 1.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.8 | 32.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 6.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 5.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 4.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 7.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 9.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 13.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.6 | 1.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 1.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 1.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 3.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 6.8 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 3.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 12.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 2.8 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 23.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 10.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 7.0 | GO:0001741 | XY body(GO:0001741) |
0.4 | 3.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 17.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 6.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 4.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 5.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.4 | 2.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 4.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.3 | 33.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 6.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 3.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 19.4 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 2.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 3.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 2.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 35.7 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 3.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 12.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 13.3 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 1.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 2.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 2.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 10.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 9.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 3.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.9 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 9.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.4 | 10.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.3 | 9.9 | GO:0051373 | FATZ binding(GO:0051373) |
2.8 | 11.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.5 | 7.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.3 | 11.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 6.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.9 | 5.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.8 | 5.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.8 | 5.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.8 | 7.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.7 | 8.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.7 | 8.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.7 | 6.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.7 | 5.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.5 | 13.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 7.5 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 4.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 8.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.4 | 9.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.3 | 3.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 3.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 3.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 5.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.1 | 5.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.0 | 5.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.0 | 3.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 5.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 2.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 3.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 2.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 8.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.9 | 1.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 2.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.9 | 2.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.9 | 2.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 4.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 2.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.8 | 5.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 8.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 3.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.7 | 11.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 4.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 3.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 2.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 2.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 2.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.6 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 3.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 3.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 4.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 1.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 1.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 18.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 1.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 2.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 3.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 1.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 2.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 5.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 2.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 7.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 7.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 0.5 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 3.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 12.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 2.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 5.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 4.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 3.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 1.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 1.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 7.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 2.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 3.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 3.8 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 7.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 3.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 3.2 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 1.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 3.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 9.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 6.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 2.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 0.9 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 3.7 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 1.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.3 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 0.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 0.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 4.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 3.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 1.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 3.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 3.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 2.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 2.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 0.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.3 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 6.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 10.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 6.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 3.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 4.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 20.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 1.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 3.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.7 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 1.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 2.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 2.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 3.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 1.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 3.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 5.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 2.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 2.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 4.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 2.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 3.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 7.7 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 3.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0018561 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 2.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 3.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 25.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 1.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 6.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 2.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 3.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 3.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 23.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.4 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 12.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 13.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 8.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 11.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 14.3 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 5.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 4.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 7.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 10.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 5.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 10.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 5.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 3.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 7.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 4.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 5.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 14.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 4.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 20.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 9.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 2.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 3.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 26.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.7 | 1.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.9 | 18.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 20.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.8 | 29.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 15.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.7 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 9.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 12.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 10.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 21.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 3.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 8.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 5.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 3.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 5.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 5.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 4.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 4.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 14.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 1.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 11.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 4.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 4.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 6.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 3.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 0.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 8.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 2.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 2.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 4.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 7.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 3.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 1.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 6.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 1.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 2.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 6.1 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 2.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 2.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 4.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.1 | 2.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 3.7 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 0.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 11.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 2.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 5.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 1.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |